106 related articles for article (PubMed ID: 8560999)
21. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
Fernandes EO; Moraes RS; Ferlin EL; Wender MC; Ribeiro JP
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S172-7. PubMed ID: 15683490
[TBL] [Abstract][Full Text] [Related]
22. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
Brynhildsen J; Hammar M
Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
[TBL] [Abstract][Full Text] [Related]
23. Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement.
Sørensen MB; Fritz-Hansen T; Jensen HH; Pedersen AT; Højgaard L; Ottesen B
Am J Obstet Gynecol; 2001 Jan; 184(2):41-7. PubMed ID: 11174477
[TBL] [Abstract][Full Text] [Related]
24. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women.
Sudhir K; Elser MD; Jennings GL; Komesaroff PA
Hypertension; 1997 Dec; 30(6):1538-43. PubMed ID: 9403579
[TBL] [Abstract][Full Text] [Related]
25. Effects of acute carbohydrate administration on central and peripheral hemodynamic responses to mental stress.
Jern S
Hypertension; 1991 Dec; 18(6):790-7. PubMed ID: 1743760
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
Notelovitz M; Cassel D; Hille D; Furst KW; Dain MP; VandePol C; Skarinsky D
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
[TBL] [Abstract][Full Text] [Related]
27. [Behavior the lipid spectrum following complete ovariectomy and subsequent substitution with estradiol valerate or norethisterone acetate].
Hempel E; Illessy G; Schubert KH
Zentralbl Gynakol; 1987; 109(21):1285-9. PubMed ID: 3434006
[TBL] [Abstract][Full Text] [Related]
28. Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution.
Luotola H
Ann Clin Res; 1983; 15 Suppl 38():1-121. PubMed ID: 6367617
[TBL] [Abstract][Full Text] [Related]
29. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
Cacciatore B; Paakkari I; Hasselblatt R; Nieminen MS; Toivonen J; Tikkanen MI; Ylikorkala O
Am J Obstet Gynecol; 2001 Apr; 184(5):904-9. PubMed ID: 11303197
[TBL] [Abstract][Full Text] [Related]
30. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
31. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
32. Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress.
Nóbrega AC; Carvalho AC; Santos KB; Soares PP
Clin Auton Res; 1999 Feb; 9(1):11-6. PubMed ID: 10212743
[TBL] [Abstract][Full Text] [Related]
33. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women.
Sudhir K; Jennings GL; Funder JW; Komesaroff PA
Hypertension; 1996 Sep; 28(3):330-4. PubMed ID: 8794812
[TBL] [Abstract][Full Text] [Related]
34. Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
Bladbjerg EM; Skouby SO; Andersen LF; Jespersen J
Hum Reprod; 2002 Dec; 17(12):3235-41. PubMed ID: 12456630
[TBL] [Abstract][Full Text] [Related]
35. Systemic vascular hemodynamic changes due to 17-β-estradiol intranasal administration.
Ciccone MM; Scicchitano P; Gesualdo M; Fornarelli F; Pinto V; Farinola G; Lagioia R; Sassara M; Zito A; Federici A; Cicinelli E
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):354-8. PubMed ID: 23624711
[TBL] [Abstract][Full Text] [Related]
36. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy.
Wihlbäck AC; Sundström-Poromaa I; Nyberg S; Bäckström T
Neuroendocrinology; 2001 Jun; 73(6):397-407. PubMed ID: 11408781
[TBL] [Abstract][Full Text] [Related]
38. Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions.
Christensen MS; Hagen C; Christiansen C; Transbøl I
Am J Obstet Gynecol; 1982 Dec; 144(8):873-9. PubMed ID: 6756151
[TBL] [Abstract][Full Text] [Related]
39. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
40. Effect of low-dose estrogen on hemodynamic response to stress.
Meyer WR; Costello N; Straneva P; West S; Copeland K; Girdler S
Fertil Steril; 2001 Feb; 75(2):394-9. PubMed ID: 11172846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
